Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Redeye: Cimco Marine - Time to rev up sales

Redeye updates its coverage of Cimco Marine, a high-risk turnaround case. Its innovative diesel outboards, which break new ground by combining belt propulsion with automotive engines, offer superior performance, environmental impact and safety while benefiting from a growing shift towards high-power, diesel outboards. We update our coverage with a cautious stance to the stock at this point, arguing that the market has overlooked the company’s once again revised targets and slower than expected sales ramp-up. Read more and download the research update: http://bit.ly/37cpqlr Start

Redeye: Better Collective - Betting on 2020 - Adding to our Conviction Buy List

As the world’s No. 1 sports betting affiliate with clear competitive advantages and less regulatory risk than its peers, Better Collective offers investors an attractive, shareholder-friendly exposure to an undervalued industry with a stronger outlook than the challenged casino sector. Furthermore, the 2020 outlook for Better Collective looks very promising with several catalysts, such as the UEFA EURO 2020 and the US operations kicking off. We expect the strong underlying performance to continue, with rapid growth and a scaling business model. We also expect value-adding acquisitions,

Dutch hospital expands its use of Sectra’s medical imaging solution to include digital pathology

Linköping, Sweden and Almere, the Netherlands – January 22, 2020 – International medical imaging IT and cybersecurity company Sectra  (STO: SECT B) has signed a digital pathology contract with the Dutch hospital Zuyderland MC. A digital pathology workflow makes it possible to access and share images and information between departments and hospitals. Storing, reviewing and sharing digital pathology images increases efficiency in primary diagnostics and improves cancer care by facilitating the handling of complex cases.With digital images of tissue samples instead of

SBB elects to repay additional SEK 3.9 billion in secured bank debt as part of its ambition to achieve a BBB+ rating - financial costs decrease by SEK 88 million

Samhällsbyggnadsbolaget i Norden AB (publ) (“SBB”) is planning, as of 31 January 2020, to repay a secured bank loan of SEK 3.9 billion. The repayment results in lower financial costs on a 12-month rolling basis (everything else being equal) of SEK 88 million. The repayment is part of SBB's aim to achieve a BBB+ rating. SBB will continue to repay bank loans.

Redeye: AroCell - Funding secured, next step - FDA

We adjust our financial projections given a new view on pricing and market uptake for AroCell. In our update we slightly raise our Base Case to SEK 2.5 per share and discuss the capital raise, which we believe will fund operations until FDA approval in 2021. Read more and download the research update: http://bit.ly/2RRyNRh Start following companies at Redeye to receive the latest equity research within Life Science and Technology. This is a press release from Redeye - Research Powered Investment Banking. https://www.redeye.se/about/

Year-End Report 2019

“Investor’s long-term success ultimately depends on our companies’ ability to outperform global competition. As an engaged owner, we drive and support initiatives to achieve sustainable profitable growth through innovation, geographical expansion, operational excellence and structural changes.”Johan Forssell, CEO of Investor  Highlights during the fourth quarter •    Adjusted net asset value (NAV) amounted to SEK 485,019m (SEK 634 per share) on December 31, 2019, an increase of SEK 29,098m, or 6 percent during the quarter. Total shareholder return amounted to 7 percent during the

Quarterly Report I 19/20

September 2019 – November 2019, Diamyd Medical AB (publ), Fiscal year 2019/2020Developing therapies for type 1 diabetesDiamyd Medical’s B-share is traded on Nasdaq First North Growth Market under the ticker DMYD B.Further information is available on https://www.diamyd.com Figures in parentheses relate to the corresponding period previous financial year. September 1, 2019 – November 30, 2019 · Net income: MSEK 0.1 (0.3) · Net result: MSEK -6.8 (-8.5) · Result per share: SEK -0.1 (-0.2) · Cash flow from operating activities: MSEK -6.1 (-10.8) · Liquid assets and

Wihlborgs lets office space to Mindpark and Softhouse at Slagthuset in Malmö

Wihlborgs has signed agreements with two new tenants for a total of 2,400 m² at Slagthuset in MalmöThe coworking & conference enterprise Mindpark is moving in to 1,300 m² on the bottom three floors of the Slagthuset high-rise where they will, together with Goto 10 – a concept from the Internet Foundation in Sweden – manage coworking, reception, conference, café and event facilities. Mindpark was recently selected as the best coworking space in all of the Nordics. The redevelopment will begin soon and create a brand new reception as well as modern creative workplaces and conference rooms.

Ideagen Kicks Off New Decade with Strong H1 Results and Positive Growth Predictions

The UK-based global software firm today unveiled its unaudited interim results for the six months to 31[st] October 2019Highlights include; · Adjusted EBITDA** on an IFRS16 basis grew 38% to £8.0 million (H1 2018: £5.8 million on an IAS17 basis) · Adjusted EBITDA** on a like for like IAS17 basis (note 2) grew 30% to £7.5 million (H1 2018: £5.8 million).  · Adjusted diluted EPS*** increased by 17% to 2.31pence (H1 2018:1.98pence) · 30% rise in revenues to £27.3m (£21m in H1 2018) · Recurring revenues represented 74% of total revenue (67% in H1 2018) · Annual Recurring

Handelsbanken’s year-end report for January-December 2019 will be presented on February 5

Handelsbanken will present its results for January­‑December 2019 in Stockholm on February 5, 2020, at 9:00 a.m. CET, at a meeting with the media and analysts. The year-end report for January‑December 2019 will be published at 7:00 a.m. CET, on February 5, 2020. A telephone conference will be held at 10:30 a.m. CET (4:30 a.m. EST), when Rolf Marquardt, CFO, will present and comment on the results. There willalso be time for questions from the participants. UK number: +44 333–300 0804 Swedish number: +46 8–566 426 51 US number: +1 631–913 1422 PIN code: 16782668#

Hansa Biopharma to host conference call to provide Year-End report 2019 and Business Update

Lund, Sweden January 22, 2020. Hansa Biopharma will publish its Year-End report 2019 at 8:00 a.m. CET on February 6, 2020. All interested parties are invited to participate in a telephone conference, which will include a presentation of the interim results and a business update, on the same date at 2:00 p.m. CET. The event will be hosted by Hansa Biopharma’s CEO, Søren Tulstrup, and CFO, Donato Spota, and the presentation will be held in English. Slides used in the presentation will be live on the company website during the call under “Events & Webcast,” and will also be made available

Eddy Cojulun New Chief Sales Officer at Envirotainer

January 22[nd], 2020 - Envirotainer, the global market leader in secure cold chain solutions for air transport of pharmaceuticals, today announced that Eddy Cojulun joined Envirotainer as the new Chief Sales Officer (CSO) in December 2019. In his new role Eddy will report directly to the CEO and is part of the Envirotainer Management Team.Eddy brings more than 25 years of international leadership experience from various sales roles across the globe. Prior to joining Envirotainer he held multiple senior sales positions within telecom giant Ericsson. Before joining Ericsson, Eddy was the

Handelsbanken: Sunrise or a false dawn?

Following the worldwide slump in growth last year, we are now seeing green shoots of optimism. Nonetheless, Handelsbanken explains in a new macroeconomic forecast that it expects weak growth the Swedish economy, with unemployment set to rise. “Households and enterprises can count on low interest rates going forward,” says the Bank’s Chief Economist, Christina Nyman.Growth in Sweden increased merely by around 1% last year, due to less housing being built and the weakening of the global economy. Forward-looking indicators in Sweden do not yet signal any reversal of this trend, and the Bank’

Alma Media expands its cooperation with Digitaalinen asuntokauppa DIAS

Alma Media Corporation       Press release  22 January 2020 ALMA MEDIA EXPANDS ITS COOPERATION WITH DIGITAALINEN ASUNTOKAUPPA DIAS Alma Media is initiating a strategic partnership with DIAS, a digital service platform for real estate transactions. Alma Talent Oy has also agreed on the acquisition of a 5% shareholding in Digitaalinen asuntokauppa DIAS Oy.  Developed by the Finnish software house Tomorrow Tech, DIAS is a digital platform for real estate transactions that brings together home buyers, sellers, real estate agents, developers and banks. The platform enables the secure

The subscription period for TO1 starts today

As part of Insplorion's previous financing strategy with ESGO, the company has distributed free options to the company's shareholders to counter dilution. Today, on January 22, the second subscription period commences to exchange the options (TO1) for shares. The subscription period runs until February 5, 2020.The subscription price is SEK 11.50 per share in accordance with the conversion of the subscription price following the rights issue that was carried out in 2019, see § 8.11 in TERMS OF SUBSCRIPTION OPTIONS IN INSPLORION AB (PUBL) SERIES TO1 2018/2023. In the event that the holder

Positive opinion received from EMA Paediatric Committee on the Paediatric Investigation Plan for Nefecon for the treatment of IgAN

Calliditas Therapeutics AB (publ) (“Calliditas”) today announced that the EMA Paediatric Committee (PDCO) has adopted a positive opinion on the Paediatric Investigation Plan (PIP) for Nefecon for the treatment of primary IgA nephropathy (IgAN).With successful completion of the agreed PIP, Nefecon would be eligible for up to an additional two years of marketing exclusivity in the EU, on top of the ten-year EU market exclusivity after market approval. As part of the regulatory process for the registration of new medicines in Europe, pharmaceutical companies are required to provide a PIP

MAG Interactive AB (publ) publishes interim report September – November 2019/2020

Increased revenues and strengthened EBITDA in the financial year’s first quarterSummary of the period September – November 2019: ·The Group's net sales for the period were 47,102 KSEK (40,367 KSEK), an increase of 17% compared to the same period the previous year  ·EBITDA for the period was 5,029 KSEK (1,230 KSEK)  ·The Group's game contribution for the period was 31,373 KSEK (25,850 KSEK), an increase of 21% compared to the same period the previous year ·ARPDAU for the period was 2.9 US cents (2.2 US cents), an increase of 33% compared to the same period last

Wärtsilä’s new 100 MW energy storage project in South East Asia to boost regional grid stability

Wärtsilä Corporation, Press release, 22 January 2020 at 9.00 am EETThe technology group Wärtsilä has signed an Engineering, Procurement and Construction (EPC) contract for a new 100 MW/100 MWh total capacity energy storage project in South East Asia. The energy storage system facility, including Wärtsilä’s GEMS, an advanced energy management software platform, and GridSolv solution, will be used for grid support purposes. The order was booked with Wärtsilä in Q4 2019. This contract comes in addition to the similar size contract announced in July 2019.  Wärtsilä is enabling the

Expert evaluation clarifies Phase 3 results and provides strong support for MOB-015

STOCKHOLM, January 22[nd], 2020. Moberg Pharma AB (OMX: MOB) has now completed the expert evaluation of the results from the North American Phase 3-study. The analysis conducted with key opinion leaders (KOLs) has confirmed the validity of the data presented in December 2019 and increased the understanding of the study outcomes. Key conclusions include: i) MOB-015 delivers a very high mycological cure rate that compares favorably to oral antifungal drugs with the added advantage of an earlier onset of action; ii) Confirmation that the proprietary vehicle technology increases the hydration and

Transcom Holding AB (publ): Invitation to Transcom fourth quarter 2019 results presentation

Transcom are pleased to invite you to their Q4 2019 financial update call on Friday, February 14, 2020 at 9:00 CET, following the release of Q4 2019 results at 8:00 am CET. The press release will include the presentation for the call. The materials will also be available on https://www.transcom.com/en/investor-relations. Representing Transcom Jonas Dahlberg, President & CEO Presentation details Date/Time: Friday, February 14, 2020 at 9:00 CET Online Registration link: http://emea.directeventreg.com/registration/6352076 Important note: Please register via the link above at

Flexion expands deal with YOOZOO Games

Saint Seiya Awakening included in the new agreementLONDON, 22th of January, 2020 – Flexion Mobile Plc (Nasdaq: FLEXM) , today confirmed that it has expanded its agreement with YOOZOO Games to include the new title Saint Seiya Awakening. The title was released by YOOZOO Games in September and is already performing exceptionally well in Google Play. The beautifully crafted 3D game is based on the classic Japanese manga anime series from the 1980s that got known in the West after it became popular in France.  "We are super excited about our partnership with YOOZOO

New names on Azelio's shareholder list after oversubscribed rights issue

Azelio recently completed an oversubscribed rights issue of SEK 350 million. In connection with the share issue, Ilija Batljan entered as the fifth largest shareholder in Azelio, together with many private and institutional investors.At the end of December 2019, Azelio announced an oversubscribed rights issue of SEK 350 million. The announcement was made along with the news that Azelio started up its verification project in Morocco. After the rights issue, Blue Marlin AB remains the largest shareholder of the company and Back in Black Capital Ltd is now the second largest shareholder. Many

Halton Group opens its 9th Innovation Hub in Germany

Halton Group, which focuses on indoor air systems for demanding indoor environments, has opened new research and development premises, a Halton Innovation Hub, connected to its German factory in Reit im Winkl. The new hub focuses on testing and measurements of ventilation and air flow in professional kitchens, with a view to strengthening the company’s position in the market.Testing and validating the functionality of systems tailored for demanding customer environments is essential to Halton’s way of operating and of serving customers. The Innovation Hub is bringing new scope and accuracy

Mycronic implements new group structure

Mycronic AB (publ) has grown substantially during the last years, both organically and through acquisitions. In order to prepare for continued profitable growth, a new group structure is implemented in order to achieve the strategic priorities of improving profitability in Assembly Solutions, securing and expanding the position in Pattern Generators and enhancing customer centricity. The new Mycronic organization will be made up of four divisions: Assembly Solutions High FlexFocus on high flex assembly markets, primarily in Europe and the US. Includes current SMT and Inspection

There are no items matching the current filter
There are no more items matching the current filter
Back to top